GlassScriptPhysician profile
Jing Liang
NPI 1770842825
$766.67
in general payments reported to CMS, 2019-2025
8 companies · $80.70 in 2025
The $80.70 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.43 · 2023: $294 · 2024: $348 · 2025: $80.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $367.44 | 2022-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $135.70 | 2024 | Iovera, Exparel, Zilretta |
| Boston Scientific Corporation | $129.75 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $34.38 | 2024-2025 | |
| Gilead Sciences, INC. | $30.18 | 2022 | |
| Orthofix Medical, INC. | $25.21 | 2024 | Physio-Stim |
| Curonix LLC | $23.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $20.57 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jing Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.